Alzheimer’s disease

Alzheimer’s disease could be caused by damage to a protective barrier in the body that allows fatty substances to build up in the brain.

Harley Street’s London Alzheimer’s Clinic to offer Transcranial Pulse Stimulation, a revolutionary new treatment for Alzheimer’s dementia.

Exposure to nanoparticles during cooking causes changes to brain activity similar to that observed in early-stage Alzheimer’s disease.

Take a cell-deep tour of a brain afflicted with Alzheimer’s disease, and you will find minuscule clumps of protein that seem suspicious.

Heart disease can directly cause brain dysfunction early on which could lead to dementia and can treble the amount of an Alzheimer’s protein in the brain.

A new Cleveland Clinic-led study has identified sildenafil as a promising drug candidate to help prevent and treat Alzheimer’s disease.

There are two specific proteins known to be found in aggregated ‘clumps’ in Alzheimer’s patients.

The researchers used post-mortem brain samples from Alzheimer’s patients, as well as PET scans from living patients.

Poor sleep and Alzheimer’s disease are both associated with cognitive decline, and separating out the effects of each has proven challenging.

Photobiomodulation refers to the low-power light in the visible and near-infrared spectra to trigger beneficial biological processes in cells and tissues.

Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer’s disease.

Dementia has many faces, and because of the wide range of ways in which it can develop and affect patients, it can be very challenging to treat.

Cholesterol manufactured in the brain appears to play a key role in the development of Alzheimer’s disease, new research indicates.

Rutgers researchers have discovered some of the first molecular insights into how toxic proteins are regulated in neurodegenerative diseases.

Researchers developed a method that can predict the possible onset of Alzheimer’s disease from brain images with an accuracy of over 99%.